t seems like ages since President Trump castigated drug company executives for “getting away with murder” and promised to take on the powerful pharma lobby.
While the spotlight has shifted (and the threat of a crackdown has dimmed), the pharma industry still has plenty on its plate. The man charged with pushing the industry’s agenda is Stephen J. Ubl, the president and CEO of the PhRMA trade group. He stopped by the STAT offices in Boston this week to talk about his plans — and the challenges he’s confronting. Here are the highlights: